Financial limitations are a major hurdle in cancer research. Conducting high-quality research requires substantial funding, which is often limited. This affects the ability to perform large-scale clinical trials and hampers the development of new therapies. Additionally, funding disparities exist between different types of cancers, often influenced by public awareness and advocacy.
